Evopoint

688837
35.212.17% ( -0.78 )
Delay Closed: Nov 16, 15:00:00

Valuation

Current ValuationThe current P/E ratio is -33.84, within the reasonable range, cheaper than 75% of the time in the past 1 years, and the industry ranks 197/222, the industry Median 22.19.

-33.84xP/E
Stock price¥35.21Earnings per share¥-1.04

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.19x
015304560

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.19x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688506SHBIOKIN PHARMACEUTICAL
-78.91x3.45%¥99.74B
000661SZCCHT
-70.66x551.28%¥29.95B
300255SZCSBIO
-46.66x--¥16.38B
688837SHEvopoint
-33.84x--¥15.33B
300436SZCosunter
-56.70x--¥11.90B
300363SZPorton
-121.38x13.89%¥11.62B
300006SZLummy
-95.90x--¥11.46B
002099SZHISOAR
-39.90x--¥9.36B
000908SZCSPC Jingfeng
-332.72x--¥8.50B
688505SHFudan-Zhangjiang
-67.87x--¥7.00B
002737SZSFPM
-49.58x--¥6.98B
600252SHZhongheng Group
-16.13x--¥6.75B
600129SHTAIJI GROUP
-343.14x127.27%¥6.73B
600422SHKPC
-22.47x143.48%¥6.41B
688176SHAsieris
-11.30x1.35%¥5.98B
000813SZDEZHAN HEALTHCARE
-14.98x--¥5.81B
002082SZWBDE
-39.55x--¥5.79B
300267SZER-KANG
-16.59x--¥5.75B
002424SZGZBL
-44.17x--¥5.71B
603229SHAusun Pharm
-1,233.40x106.25%¥5.59B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.